Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro

Life Sciences

Volumn 85, Issue 5-6, 2009, Pages 220-225

  Tanaka, Aki ^a   Suzuki, Yuko ^a   Sugihara, Kazuhiro ^a   Kanayama, Naohiro ^a   Urano, Tetsumei ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contact factors; Factor XII; Fibrinolysis; PAI 1; Thrombin

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 12A; CALCIUM ION; KALLIKREIN; KAOLIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN;

ARTICLE; CONTROLLED STUDY; EUGLOBULIN LYSIS TEST; FIBRINOLYSIS; HUMAN; IN VITRO STUDY; PROTEIN CLEAVAGE; THROMBIN TIME;

BLOOD COAGULATION TESTS; COAGULANTS; FACTOR XIA; FACTOR XIIA; FIBRINOLYSIS; HUMANS; KALLIKREINS; KAOLIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN INACTIVATORS; SERINE PROTEINASE INHIBITORS; SERUM GLOBULINS; THROMBIN; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 67649781655     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.05.014     Document Type: Article

References (24)

1. Berrettini M., Schleef R.R., Espana F., Loskutoff D.J., and Griffin J.H. Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system. Journal of Biological Chemistry 264 20 (1989) 11738-11743
2. Chavakis T., Kanse S.M., Lupu F., Hammes H.P., Muller-Esterl W., Pixley R.A., Colman R.W., and Preissner K.T. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Blood 96 2 (2000) 514-522
3. Chavakis T., Pixley R.A., Isordia-Salas I., Colman R.W., and Preissner K.T. A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor-1 function. Journal of Biological Chemistry 277 36 (2002) 32677-32682
4. Colman R.W. Surface-mediated defense reactions. The plasma contact activation system. Journal of Clinical Investigation 73 5 (1984) 1249-1253
5. Ehrlich H.J., Gebbink R.K., Keijer J., Linders M., Preissner K.T., and Pannekoek H. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties. Journal of Biological Chemistry 265 22 (1990) 13029-13035
6. Gaffney P.J., Edgell T.A., and Whitton C.M. The haemostatic balance-Astrup revisited. Haemostasis 29 1 (1999) 58-71
7. Goldsmith Jr. G.H., Saito H., and Ratnoff O.S. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments. Journal of Clinical Investigation 62 1 (1978) 54-60
8. Ichinose A., Fujikawa K., and Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. Journal of Biological Chemistry 261 8 (1986) 3486-3489
9. Kaplan A.P., and Silverberg M. The coagulation-kinin pathway of human plasma. Blood 70 1 (1987) 1-15
10. Kluft C., Dooijewaard G., and Emeis J.J. Role of the contact system in fibrinolysis. Seminars in Thrombosis and Hemostasis 13 1 (1987) 50-68
11. Lawrence D.A., Palaniappan S., Stefansson S., Olson S.T., Francis-Chmura A.M., Shore J.D., and Ginsburg D. Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis. Journal of Biological Chemistry 272 12 (1997) 7676-7680
12. Loskutoff D.J., Sawdey M., and Mimuro J. Type 1 plasminogen activator inhibitor. Progress in Hemostasis and Thrombosis 9 (1989) 87-115
13. Mandle Jr. R.J., and Kaplan A.P. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen. Blood 54 4 (1979) 850-862
14. Nielsen V.G., Steenwyk B.L., and Gurley W.Q. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII. Journal of Heart and Lung Transplantation 25 10 (2006) 1247-1252
15. Niewiarowski S., and Prou-Wartelle O. [Role of the contact factor (Hageman factor) in fibrinolysis]. Thrombosis et Diathesis Haemorrhagica 3 (1959) 593-603
16. Nishikawa K., Shibayama Y., Kuna P., Calcaterra E., Kaplan A.P., and Reddigari S.R. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein. Blood 80 8 (1992) 1980-1988
17. Rijken D.C., and Lijnen H.R. New insights into the molecular mechanisms of the fibrinolytic system. Journal of Thrombosis and Haemostasis 7 1 (2009) 4-13
18. Suzuki Y., Mogami H., Ihara H., and Urano T. Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells. Blood 113 (2009) 470-478
19. Travis J., and Salvesen G.S. Human plasma proteinase inhibitors. Annual Reviews of Biochemical 52 (1983) 655-709
20. Urano T., Sumiyoshi K., Pietraszek M.H., Takada Y., and Takada A. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA. Thrombosis and Haemostasis 66 4 (1991) 474-478
21. Urano T., Strandberg L., Johansson L.B., and Ny T. A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate. European Journal of Biochemistry 209 3 (1992) 985-992
22. Urano T., Ihara H., Takada Y., Nagai N., and Takada A. The inhibition of human factor Xa by plasminogen activator inhibitor type 1 in the presence of calcium ion, and its enhancement by heparin and vitronectin. Biochimica et Biophysica Acta 1298 2 (1996) 199-208
23. Urano T., Castellino F.J., Ihara H., Suzuki Y., Ohta M., Suzuki K., and Mogami H. Activated protein C attenuates coagulation-associated over-expression of fibrinolytic activity by suppressing the thrombin-dependent inactivation of PAI-1. Journal of Thrombosis and Haemostasis 1 12 (2003) 2615-2620
24. Yarovaya G.A., Blokhina T.B., and Neshkova E.A. Contact system. New concepts on activation mechanisms and bioregulatory functions. Biochemistry (Moscow) 67 1 (2002) 13-24